TuHURA Biosciences Files 8-K: Officer Changes & Other Events

Ticker: HURA · Form: 8-K · Filed: Apr 8, 2026 · CIK: 0001498382

Sentiment: neutral

Topics: corporate-governance, filing-update

TL;DR

TuHURA 8-K filed: Director/Officer changes, other events on 4/2. Check for exec comp details.

AI Summary

TuHURA Biosciences, Inc./NV filed an 8-K on April 8, 2026, reporting on the departure of a director or officer, other events, and financial statements/exhibits. The filing includes details on compensatory arrangements for certain officers and other events that occurred on April 2, 2026.

Why It Matters

This filing indicates potential shifts in the company's leadership or significant operational updates that could impact its strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors or officers, especially if unexpected, can signal internal issues or strategic shifts that may carry risks.

Key Players & Entities

FAQ

What specific officer or director departed from TuHURA Biosciences, Inc./NV?

The filing indicates Item 5.02 pertains to the 'Departure of Directors or Certain Officers,' but the specific names are not detailed in the provided summary text.

What were the 'Other Events' reported by TuHURA Biosciences on April 2, 2026?

The filing mentions 'Item 8.01: Other Events' occurred on April 2, 2026, but the specific nature of these events is not detailed in the provided summary text.

What is the significance of Item 5.02 in this 8-K filing?

Item 5.02 covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

What is the filing date and the period of report for this 8-K?

The filing date is April 8, 2026, and the period of report is April 2, 2026.

Where is TuHURA Biosciences, Inc./NV located?

The company's mailing and business address is 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2026 regarding TuHURA Biosciences, Inc./NV (HURA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing